TNXT targets companies that T. Rowe Price believes are driving transformative innovation across sectors. The fund concentrates on firms with disruptive business models, breakthrough technologies, or products reshaping their industries — think beyond just software to biotech breakthroughs, industrial automation, and emerging consumer platforms.
How It Works
T. Rowe Price applies its fundamental research process to identify innovation leaders, focusing on competitive moats, addressable markets, and management execution rather than pure growth metrics. The portfolio typically holds 30-50 names with meaningful concentration in top convictions. Unlike passive innovation ETFs that screen for R&D spending or patent counts, this actively selects companies where innovation translates to sustainable competitive advantages.
Key Features
- Active stock selection from T. Rowe Price's growth team, not a mechanical innovation screen
- Broader innovation definition includes business model disruption, not just tech hardware/software
- Concentrated portfolio allows meaningful positions in highest-conviction innovation plays
Risks
- Innovation leaders often trade at 40-60x earnings — a shift in rates or sentiment could drive 30-40% drawdowns
- High concentration means a few blown thesis calls could crater performance for quarters
- Many holdings are pre-profit or early-stage profitable, making them extremely sensitive to funding conditions
Who Should Own This
Best for investors who want professional active management in the innovation space but find ARK too concentrated in speculative names. Works as a 5-10% satellite position for long-term growth exposure. The active approach suits those uncomfortable picking individual disruptors but willing to pay for T. Rowe's research edge over passive innovation indices.